GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » FCF Margin %

ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) FCF Margin % : -165,480.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ImmuneOnco Biopharmaceuticals (Shanghai)'s Free Cash Flow for the six months ended in Jun. 2024 was €-16.55 Mil. ImmuneOnco Biopharmaceuticals (Shanghai)'s Revenue for the six months ended in Jun. 2024 was €0.01 Mil. Therefore, ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % for the quarter that ended in Jun. 2024 was -165,480.00%.

As of today, ImmuneOnco Biopharmaceuticals (Shanghai)'s current FCF Yield % is -12.82%.

The historical rank and industry rank for ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % or its related term are showing as below:

FRA:R9Z' s FCF Margin % Range Over the Past 10 Years
Min: -95963.51   Med: -48669.88   Max: -312.35
Current: -482.49

During the past 4 years, the highest FCF Margin % of ImmuneOnco Biopharmaceuticals (Shanghai) was -312.35%. The lowest was -95963.51%. And the median was -48669.88%.

FRA:R9Z's FCF Margin % is ranked worse than
69.73% of 1011 companies
in the Biotechnology industry
Industry Median: -127.22 vs FRA:R9Z: -482.49

ImmuneOnco Biopharmaceuticals (Shanghai) FCF Margin % Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) FCF Margin % Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data
Trend Dec21 Dec22 Dec23 Dec24
FCF Margin %
-6,232.81 -48,584.93 -95,100.00 -

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Margin % Get a 7-Day Free Trial -137,080.00 -156,654.55 -77,894.87 -165,480.00 -

Competitive Comparison of ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin %

For the Biotechnology subindustry, ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % falls into.


;
;

ImmuneOnco Biopharmaceuticals (Shanghai) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-47.55/0.05
=-95,100.00 %

ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-16.548/0.01
=-165,480.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuneOnco Biopharmaceuticals (Shanghai) FCF Margin % Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » FCF Margin %
Comparable Companies
HKSE:06996 HKSE:06978 HKSE:02181 HKSE:01521 HKSE:02509 HKSE:02487 HKSE:02137 HKSE:02566 HKSE:02563 HKSE:01167 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
01541:Hong Kong
Address
1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN
Website
http://cn.immuneonco.com
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines